CIK 0001712762
- Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465211056
- Phone
- +1 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- Open-market buys, last 90 days
- $1,039,671
- in 1 filing
- Open-market sales, last 90 days
- $1,175,048
- in 1 filing
Net −$135,378. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-10 | Edwards James Michael VP and CFO | Grant or award | +6,172 | 120,128 | ||
| 2024-11-05 | Edwards James Michael VP and CFO | Grant or award | +100,000 | 113,956 | ||
| 2022-11-17 | Edwards James Michael Chief Financial Officer | Grant or award | +3,619 | 36,815 | ||
| 2022-09-06 | Edwards James Michael Chief Financial Officer | Conversion | +2,243 | $4.20 | $9K | 32,566 |
| 2022-09-06 | Edwards James Michael Chief Financial Officer | Conversion · Secured Convertible Promissory Note | −0 | 0 | ||
| 2022-09-06 | Edwards James Michael Chief Financial Officer | Grant or award · Warrant (right to buy) | +1,903 | 1,903 | ||
| 2022-09-01 | Edwards James Michael Chief Financial Officer | Purchase | +2,448 | 30,323 | ||
| 2022-09-01 | Edwards James Michael Chief Financial Officer | Purchase · Warrants (right to buy) | +2,448 | 2,448 | ||
| 2022-09-01 | Edwards James Michael Chief Financial Officer | Purchase · Non-tradeable Warrants (right to buy) | +2,448 | 2,448 | ||
| 2022-07-20 | Edwards James Michael Chief Financial Officer | Grant or award · Warrant (right to buy) | +761 | 761 |
Page 1 of 1 · 10 trades